A Brief Self-compassion Intervention for Body Image, Minority Stress, and Sexual Self-efficacy in Hong Kong Gay Men

April 24, 2026 updated by: Dr Polly MA Haixia, Hong Kong Metropolitan University
This pilot study aims to explore the feasibility, acceptability, and preliminary effectiveness of a brief self-compassion writing intervention on body image, minority stress, and sexual self-efficacy among gay men in Hong Kong.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Gay men experience greater body dissatisfaction, a stronger drive for muscularity, and heightened body image concerns compared to their heterosexual counterparts. These issues contribute to minority stress, anxiety, low self-esteem, and engagement in risky sexual behaviors. Using a randomized controlled trial (RCT) design, we aim to explore the feasibility, acceptability, and preliminary effectiveness of a brief self-compassion writing intervention on body image, minority stress, and sexual self-efficacy among gay men in Hong Kong.

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Hong Kong, Hong Kong
        • Hong Kong Metropolitan University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • aged 18 years or above
  • self-identified as a gay man
  • sufficient comprehension of Cantonese
  • currently living in Hong Kong
  • able to provide informed consent

Exclusion Criteria:

  • currently experiencing psychosis
  • having an intellectual disability
  • experiencing current suicidal ideation
  • not currently receiving or engaging in regular mental health services in the last 3 months
  • participation in a similar study or receiving similar services in the past 12 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Waiting-list control group
Experimental: Self-compassion interventional group
Interventional group will include 2.5 hour training and 3 weeks self-compassion writing exercise
Participants will be randomly allocated to the self-compassion group and the waiting list control group. The interveintion group will receive a 2.5 self-compassion training, and 3 week self-compassion writing exercise.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
self-compassion
Time Frame: From enrollment to the end of intervention at 1 month
Self-compassion will be measured using the 12-item short version of the self-compassion scale (SCS). Items are rated on a 5-point Likert scale ranging from 1 (Almost Never) to 5 (Almost Always). The total score ranged from 12 to 60, with higher score indicating higher level of self-compassion.
From enrollment to the end of intervention at 1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sexuality-based stigma
Time Frame: From enrollment to the end of treatment at 1 month
Sexuality-based stigma will be measured by the 10-item Chinese men sex with men (MSM) Stigma Scale. Items are rated on a four-point Likert scale from 1 (never) to 4 (many times). The total score ranges from 10 to 40, with higher score indicating higher level of sexuality-based stigma.
From enrollment to the end of treatment at 1 month
Internalized stigma
Time Frame: From enrollment to the end of treatment at 1 month
Internalized stigma will be measured with the 5-item revised internalized homophobia scale (IHP-R). Items are measured on a five-point Likert scale between 1 (Strongly Disagree) and 5 (Strongly Agree). The total score ranges from 5 to 25, with higher scores indicate greater internalized stigma.
From enrollment to the end of treatment at 1 month
anxiety
Time Frame: From enrollment to the end of treatment at 1 month
Anxiety symptoms will be measured using the 7-item Generalized Anxiety Disorder-7 (GAD-7). Items are rated on a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day). The total score ranges from 0 to 21, with higher total scores indicating higher levels of anxiety symptoms
From enrollment to the end of treatment at 1 month
self-esteem
Time Frame: From enrollment to the end of treatment at 1 month
The 10-item Rosenberg Self-Esteem Scale (RSE) will be used to measured self-esteem. Items will be rated on a 4-point Liker scale (1 = Strongly agree, 4 = Strongly disagree). The total score ranges from 10 to 40, with higher score indicating higher level of self-esteem.
From enrollment to the end of treatment at 1 month
body objectification
Time Frame: From enrollment to the end of treatment at 1 month
Self-objectification will be measured using the Chinese version of the Objectified Body Consciousness Scale (OBCS) - body-surveillance subscale. It consists of eight items rated on a 7-point Likert scale (1 = strongly disagree to 7 = strongly agree). The total score ranges from 7 to 56, with a higher score indicating a higher level of body surveillance.
From enrollment to the end of treatment at 1 month
sexual self-efficacy
Time Frame: From enrollment to the end of treatment at 1 month
The 14-item Condom Self-Efficacy Scale (CSES) will be used to measurement participants' sexual self-efficacy. Items will be measured on a 5-point Likert scale, ranging from 1 (very unsure) to 5 (very sure). The total score ranging from 14 to 70, with higher scores indicated a higher level of condom use efficacy.
From enrollment to the end of treatment at 1 month
Body shame
Time Frame: From enrollment to the end of intervention at 1 month
Body shame will be measured using the Chinese version of the Objectified Body Consciousness Scale (OBCS) - body shame subscale (McKinley & Hyde, 1996). It consists of six items rated on a 7-point Likert scale (1 = strongly disagree to 7 = strongly agree), with a higher score indicating a higher level of body shame.
From enrollment to the end of intervention at 1 month
Depression
Time Frame: From enrollment to the end of intervention at 1 month
Depression will be measured using the Chinese version of the 9-item Patient Health Questionnaire (PHQ-9). Items are rated on a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day). The total score ranges from 0 to 27, with higher total scores indicating higher levels of depressive symptoms.
From enrollment to the end of intervention at 1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 27, 2026

Primary Completion (Estimated)

February 28, 2027

Study Completion (Estimated)

February 28, 2027

Study Registration Dates

First Submitted

January 18, 2026

First Submitted That Met QC Criteria

January 18, 2026

First Posted (Actual)

January 27, 2026

Study Record Updates

Last Update Posted (Actual)

April 29, 2026

Last Update Submitted That Met QC Criteria

April 24, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • HE-NHS2025/05
  • M2025/06 (Other Grant/Funding Number: Hong Kong Metropolitan University)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gay Men

Clinical Trials on Brief self-compassion intervention

Subscribe